Palvella Therapeutics raises $3M to advance rare disease drug

//Palvella Therapeutics raises $3M to advance rare disease drug

Palvella Therapeutics raises $3M to advance rare disease drug

Palvella Therapeutics, a Wayne-based biopharmaceutical company developing treatments for rare disease, has raised $3.4 million in an equity financing deal. The private stock sale was disclosed in documents the company filed with the Securities and Exchange Commission. The identity of the investors was not disclosed. The equity financing deal comes about four months after Palvella  entered into a $10 million development funding and royalties agreement with Ligand Pharmaceuticals. That deal enabled…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-04-15T10:40:39+00:00 April 15th, 2019|Healthcare|

About the Author: